<--- Back to Details
First PageDocument Content
Addiction / Alcoholism / Nicotine / Binge drinking / Fetal alcohol syndrome / Attention deficit hyperactivity disorder / Naltrexone / Social anxiety disorder / Major depressive disorder / Alcohol abuse / Psychiatry / Chemistry
Date: 2008-05-14 10:28:48
Addiction
Alcoholism
Nicotine
Binge drinking
Fetal alcohol syndrome
Attention deficit hyperactivity disorder
Naltrexone
Social anxiety disorder
Major depressive disorder
Alcohol abuse
Psychiatry
Chemistry

K ey Word Index gs_ASME_Book

Add to Reading List

Source URL: www.attcnetwork.org

Download Document from Source Website

File Size: 493,98 KB

Share Document on Facebook

Similar Documents

Key Techniques to Reduce Severe Injection Site Reactions ® VIVITROL (naltrexone for extended-release injectable suspension) Intramuscular Injection • Use appropriate VIVITROL needle to ensure the injection reaches the

DocID: 1uZFA - View Document

MEDICATION GUIDE VIVITROL® (viv-i-trol) (naltrexone for extended-release injectable suspension) Read this Medication Guide before you start receiving VIVITROL injections and each time you receive an injection. There may

DocID: 1udj5 - View Document

Contrave Contrave is a new medication which has been approved by the FDA for weight loss. It is a combination of naltrexone (Vivitrol, Revia) and bupropion (Wellbutrin). It contains a black box warning for suicidal thoug

DocID: 1u1gu - View Document

ATION ASSISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MEDICATION ASSISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MED SISTED TREATMENT• BUPRENORPHINE• NALTREXONE• MEDICATION ASSISTED TREATMENT• BUPRENOR

DocID: 1tG05 - View Document

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CONTRAVE® safely and effectively. See full prescribing information for CONTRAVE. CONTRAVE (naltrexone HCl and bupro

DocID: 1sTJs - View Document